A new series of 3-allylseleno-6-alkylthiopyridazines 6a-6g was synthesized by two synthetic routes from 3,6-dichloropyridazine to develop new anticancer agents. These new compounds showed antiproliferative activities against breast cancer (MCF-7) cells in CCK-8 assays, and could be promising candidates for chemotherapy of carcinomas. Compound 6e (3-allylseleno-6-pentylthiopyridazine) showed higher potency than 5FU for inhibiting the growth of these cell lines. This suggests the potential anticancer activity of compound 6e.
A new series of 3-alkylseleno-6-alkylaminopyridazines, 3-alkylseleno-6-alkyliminopyridazines, and 3-alkylseleno-6-dialkylaminopyridazines was synthesized from 3,6-dichloropyridazine for development of new anticancer agents. The process involves the selenylation, Se-alkylation, and aralkylamination (or imination). The alkylamines such as ethylamine and the dialkylamines such as dipropylamine were introduced into the 3-position of the pyridazine ring. These new compounds showed antiproliferative activities against breast cancer (MCF-7) and hepatocellular carcinoma (Hep3B) cells in CCK-8 assays and could be promising candidates for chemotherapy of carcinomas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.